FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164328152> ?p ?o ?g. }

• W3164328152 endingPage "2183" @default.
• W3164328152 startingPage "2171" @default.
• W3164328152 abstract "Results from Blinded Buprenorphine OR Neonatal morphine solution (BBORN), a previous phase III trial in infants with neonatal opioid withdrawal syndrome (NOWS), demonstrated that sublingual buprenorphine resulted in a shorter duration of treatment and shorter length of hospital stay than the comparator, oral morphine. Objectives of Buprenorphine Pharmacometric Open Label Research study of Drug Exposure (BPHORE), a new trial with buprenorphine in a similar population, were to (1) optimize initial dose, up-titration to achieve symptom control and weaning steps of pharmacologic treatment and (2) investigate safety of the revised regimen. A pharmacodynamic model linked buprenorphine exposure to NOWS symptom scores. Adaptive dose regimens were simulated using BBORN results to compare dosing regimens for times to stabilization, weaning, and cessation. A clinical trial using model informed doses (BPHORE), was conducted. Simulations indicated benefits in time to stabilization and weaning when up-titration rates increased to 30%. Stabilization time was not greatly impacted by the starting dose. Time to wean and time to cessation were dose dependent. A weaning rate of 25% shortened time to cessation. Ten infants were enrolled in BPHORE using buprenorphine starting dose of 24 µg/kg/day, 33% titration, and 15% wean rate. Five subjects required adjuvant therapy. Half-maximal effective concentration (EC50 ) values indicated maximum buprenorphine doses did not generate maximal effect size, suggesting potential efficacy of a further increased dose if a goal was to reduce the use of adjunct agents. Simulations indicated that further benefits can be gained by increasing starting doses of buprenorphine and increasing wean rates. Use of a model-based analysis to provide focused guidelines for care can be used with goals of reducing treatment time and hospital stays in infants with NOWS." @default.
• W3164328152 created "2021-06-07" @default.
• W3164328152 creator A5001565897 @default.
• W3164328152 creator A5017561115 @default.
• W3164328152 creator A5019899259 @default.
• W3164328152 creator A5021012110 @default.
• W3164328152 creator A5035855185 @default.
• W3164328152 creator A5041269947 @default.
• W3164328152 creator A5076053061 @default.
• W3164328152 date "2021-09-16" @default.
• W3164328152 modified "2023-10-18" @default.
• W3164328152 title "Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome" @default.
• W3164328152 cites W1907667216 @default.
• W3164328152 cites W1928789054 @default.
• W3164328152 cites W1932684871 @default.
• W3164328152 cites W1973442967 @default.
• W3164328152 cites W1990691323 @default.
• W3164328152 cites W1996361049 @default.
• W3164328152 cites W2009748772 @default.
• W3164328152 cites W2033991790 @default.
• W3164328152 cites W2039011163 @default.
• W3164328152 cites W2040327352 @default.
• W3164328152 cites W2045883317 @default.
• W3164328152 cites W2064143920 @default.
• W3164328152 cites W2213706664 @default.
• W3164328152 cites W2318728167 @default.
• W3164328152 cites W2536284946 @default.
• W3164328152 cites W2610226880 @default.
• W3164328152 cites W2763102017 @default.
• W3164328152 cites W2767933773 @default.
• W3164328152 cites W2790997532 @default.
• W3164328152 cites W2793801981 @default.
• W3164328152 cites W2914316397 @default.
• W3164328152 cites W2932780598 @default.
• W3164328152 cites W2981323645 @default.
• W3164328152 cites W3003051120 @default.
• W3164328152 cites W3010659542 @default.
• W3164328152 cites W3087585224 @default.
• W3164328152 cites W3093906108 @default.
• W3164328152 cites W3110689079 @default.
• W3164328152 cites W3117513638 @default.
• W3164328152 cites W3164328152 @default.
• W3164328152 doi "https://doi.org/10.1111/cts.13074" @default.
• W3164328152 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8604235" @default.
• W3164328152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34080312" @default.
• W3164328152 hasPublicationYear "2021" @default.
• W3164328152 type Work @default.
• W3164328152 sameAs 3164328152 @default.
• W3164328152 citedByCount "3" @default.
• W3164328152 countsByYear W31643281522021 @default.
• W3164328152 countsByYear W31643281522023 @default.
• W3164328152 crossrefType "journal-article" @default.
• W3164328152 hasAuthorship W3164328152A5001565897 @default.
• W3164328152 hasAuthorship W3164328152A5017561115 @default.
• W3164328152 hasAuthorship W3164328152A5019899259 @default.
• W3164328152 hasAuthorship W3164328152A5021012110 @default.
• W3164328152 hasAuthorship W3164328152A5035855185 @default.
• W3164328152 hasAuthorship W3164328152A5041269947 @default.
• W3164328152 hasAuthorship W3164328152A5076053061 @default.
• W3164328152 hasBestOaLocation W31643281521 @default.
• W3164328152 hasConcept C111113717 @default.
• W3164328152 hasConcept C112705442 @default.
• W3164328152 hasConcept C126322002 @default.
• W3164328152 hasConcept C170493617 @default.
• W3164328152 hasConcept C2777288759 @default.
• W3164328152 hasConcept C2778949969 @default.
• W3164328152 hasConcept C2779418921 @default.
• W3164328152 hasConcept C2780655333 @default.
• W3164328152 hasConcept C2781063702 @default.
• W3164328152 hasConcept C2908647359 @default.
• W3164328152 hasConcept C42219234 @default.
• W3164328152 hasConcept C71924100 @default.
• W3164328152 hasConcept C98274493 @default.
• W3164328152 hasConcept C99454951 @default.
• W3164328152 hasConceptScore W3164328152C111113717 @default.
• W3164328152 hasConceptScore W3164328152C112705442 @default.
• W3164328152 hasConceptScore W3164328152C126322002 @default.
• W3164328152 hasConceptScore W3164328152C170493617 @default.
• W3164328152 hasConceptScore W3164328152C2777288759 @default.
• W3164328152 hasConceptScore W3164328152C2778949969 @default.
• W3164328152 hasConceptScore W3164328152C2779418921 @default.
• W3164328152 hasConceptScore W3164328152C2780655333 @default.
• W3164328152 hasConceptScore W3164328152C2781063702 @default.
• W3164328152 hasConceptScore W3164328152C2908647359 @default.
• W3164328152 hasConceptScore W3164328152C42219234 @default.
• W3164328152 hasConceptScore W3164328152C71924100 @default.
• W3164328152 hasConceptScore W3164328152C98274493 @default.
• W3164328152 hasConceptScore W3164328152C99454951 @default.
• W3164328152 hasFunder F4320309888 @default.
• W3164328152 hasIssue "6" @default.
• W3164328152 hasLocation W31643281521 @default.
• W3164328152 hasLocation W31643281522 @default.
• W3164328152 hasLocation W31643281523 @default.
• W3164328152 hasLocation W31643281524 @default.
• W3164328152 hasOpenAccess W3164328152 @default.
• W3164328152 hasPrimaryLocation W31643281521 @default.
• W3164328152 hasRelatedWork W2005481147 @default.
• W3164328152 hasRelatedWork W2021319218 @default.

• next